Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new page revision label 'Revision: v3.6.5' is added to the history, replacing the previous 'Revision: v3.6.4'. This indicates a minor frontend update to the record page without changes to study data or results.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed from the list, reflecting an update to the record's version history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now includes a newer revision (v3.6.3) replacing the previous revision (v3.6.2), indicating an update to the study record.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter area expanded with additional site-wide links and policy text, representing a system-wide footer update rather than changes to the study content.SummaryDifference31%

- Check67 days agoChange DetectedThe study record history now shows two Results Submission Events instead of one, indicating an additional results submission event reflected in the history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe study record now shows that no participants are being sought, updating the recruitment status. A new revision tag, v3.6.0, has been added to the history to reflect an updated record version.SummaryDifference0.4%

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.